HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Haberer Selected Research

Cisplatin (Platino)

11/2013Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Haberer Research Topics

Disease

39Neoplasms (Cancer)
04/2024 - 05/2002
11Chordoma
02/2024 - 05/2002
9Chondrosarcoma
02/2024 - 05/2002
7Glioblastoma (Glioblastoma Multiforme)
10/2022 - 09/2010
7Glioma (Gliomas)
01/2022 - 10/2010
6Prostatic Neoplasms (Prostate Cancer)
02/2024 - 08/2011
6Meningioma (Meningiomas)
01/2018 - 04/2010
6Adenoid Cystic Carcinoma (Cylindroma)
02/2016 - 06/2003
5Hepatocellular Carcinoma (Hepatoma)
06/2024 - 02/2011
3AIDS-Related Complex (ARC)
10/2022 - 05/2021
2Necrosis
02/2024 - 11/2003
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2023 - 07/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023 - 05/2012
2Fatigue
12/2022 - 05/2016
2Adenocarcinoma
10/2022 - 09/2022
2Hypoxia (Hypoxemia)
05/2021 - 12/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2017 - 05/2012
2Cardiac Arrhythmias (Arrythmia)
04/2015 - 04/2015
2Brain Neoplasms (Brain Tumor)
10/2013 - 03/2012
1Unilateral Breast Neoplasms
01/2024
1Radiation Pneumonitis
01/2024
1Breast Neoplasms (Breast Cancer)
01/2024
1Hearing Loss (Hearing Impairment)
10/2023
1Ewing Sarcoma (Sarcoma, Ewing)
12/2022
1Brain Injuries (Brain Injury)
01/2022
1Lymphoma (Lymphomas)
07/2019
1Thymoma (Thymic Carcinoma)
12/2018
1Pain (Aches)
05/2016
1Fistula
05/2016
1Mucositis
09/2015
1Colonic Neoplasms (Colon Cancer)
11/2013
1Dysuria
08/2011
1Nocturia
08/2011

Drug/Important Bio-Agent (IBA)

42CarbonIBA
02/2024 - 05/2002
33IonsIBA
02/2024 - 05/2002
23Protons (Proton)IBA
02/2024 - 07/2008
8HeliumIBA
02/2024 - 08/2016
4Oxygen (Dioxygen)IBA
09/2022 - 01/2014
4GemcitabineFDA Link
01/2017 - 01/2012
3Temozolomide (Temodar)FDA LinkGeneric
09/2013 - 09/2010
2Radiation-Sensitizing AgentsIBA
01/2022 - 12/2017
2CamptothecinIBA
11/2013 - 01/2012
2Paclitaxel (Taxol)FDA LinkGeneric
11/2013 - 01/2012
11- methyl- 4- cyclohexyl- 1,2,3,6- tetrahydropyridineIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
12/2017
1DNA-Activated Protein KinaseIBA
12/2017
1temsirolimusFDA Link
01/2017
1Cisplatin (Platino)FDA LinkGeneric
11/2013
1MethyltransferasesIBA
09/2013
1Fibronectins (Fibronectin)IBA
05/2012
1IntegrinsIBA
05/2012
1VitronectinIBA
05/2012
1Hematoxylin (Haematoxylon)IBA
11/2003
1Eosine Yellowish-(YS) (Eosin)IBA
11/2003

Therapy/Procedure

35Therapeutics
06/2024 - 01/2011
28Heavy Ion Radiotherapy
06/2024 - 05/2002
25Radiotherapy
02/2024 - 05/2002
5Re-Irradiation
03/2012 - 02/2004
4Drug Therapy (Chemotherapy)
07/2013 - 10/2010
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2024 - 09/2015
2Proton Therapy
01/2024 - 01/2022
1Mastectomy (Mammectomy)
01/2024
1Molecular Targeted Therapy
01/2017
1Operative Surgical Procedures
02/2016
1Catheters
04/2015
1Drug Tapering
02/2015
1Chemoradiotherapy
09/2010
1Aftercare (After-Treatment)
04/2010
1Synchrotrons
08/2002